ICU Medical, Inc. $ICUI Holdings Lifted by SG Americas Securities LLC

SG Americas Securities LLC increased its position in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 117.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,832 shares of the medical instruments supplier’s stock after acquiring an additional 4,767 shares during the period. SG Americas Securities LLC’s holdings in ICU Medical were worth $1,141,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. Maryland State Retirement & Pension System boosted its position in shares of ICU Medical by 2.0% during the 4th quarter. Maryland State Retirement & Pension System now owns 3,619 shares of the medical instruments supplier’s stock valued at $516,000 after purchasing an additional 70 shares in the last quarter. Oregon Public Employees Retirement Fund grew its stake in shares of ICU Medical by 1.8% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 5,631 shares of the medical instruments supplier’s stock worth $803,000 after purchasing an additional 100 shares during the last quarter. Smartleaf Asset Management LLC raised its holdings in shares of ICU Medical by 11.6% in the 2nd quarter. Smartleaf Asset Management LLC now owns 969 shares of the medical instruments supplier’s stock worth $128,000 after purchasing an additional 101 shares in the last quarter. Lido Advisors LLC raised its holdings in shares of ICU Medical by 4.5% in the 4th quarter. Lido Advisors LLC now owns 2,479 shares of the medical instruments supplier’s stock worth $354,000 after purchasing an additional 106 shares in the last quarter. Finally, BNP Paribas Financial Markets raised its holdings in shares of ICU Medical by 4.5% in the 2nd quarter. BNP Paribas Financial Markets now owns 2,459 shares of the medical instruments supplier’s stock worth $325,000 after purchasing an additional 107 shares in the last quarter. 96.10% of the stock is currently owned by institutional investors.

Insider Activity at ICU Medical

In other ICU Medical news, VP Virginia Ruth Sanzone sold 2,447 shares of ICU Medical stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $124.08, for a total transaction of $303,623.76. Following the transaction, the vice president directly owned 19,460 shares in the company, valued at approximately $2,414,596.80. The trade was a 11.17% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director David C. Greenberg sold 2,424 shares of the business’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $122.91, for a total transaction of $297,933.84. Following the sale, the director directly owned 7,960 shares in the company, valued at approximately $978,363.60. This trade represents a 23.34% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 2.10% of the stock is currently owned by corporate insiders.

ICU Medical Price Performance

NASDAQ ICUI opened at $154.97 on Friday. The company has a current ratio of 2.34, a quick ratio of 1.17 and a debt-to-equity ratio of 0.60. ICU Medical, Inc. has a 1 year low of $107.00 and a 1 year high of $160.29. The company has a market cap of $3.87 billion, a PE ratio of 83.77, a PEG ratio of 2.17 and a beta of 0.76. The stock’s 50-day moving average price is $133.71 and its two-hundred day moving average price is $138.59.

ICU Medical (NASDAQ:ICUI) last announced its earnings results on Thursday, May 7th. The medical instruments supplier reported $1.97 EPS for the quarter, topping the consensus estimate of $1.78 by $0.19. The company had revenue of $525.77 million during the quarter, compared to analysts’ expectations of $520.65 million. ICU Medical had a net margin of 2.15% and a return on equity of 7.50%. The business’s revenue for the quarter was down 12.3% on a year-over-year basis. During the same period last year, the company posted $1.72 earnings per share. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. On average, analysts predict that ICU Medical, Inc. will post 6.5 EPS for the current year.

Wall Street Analyst Weigh In

ICUI has been the subject of a number of research reports. KeyCorp reduced their target price on shares of ICU Medical from $180.00 to $164.00 and set an “overweight” rating for the company in a report on Monday, April 27th. Piper Sandler dropped their price target on ICU Medical from $178.00 to $163.00 and set an “overweight” rating on the stock in a report on Friday, April 17th. Zacks Research upgraded ICU Medical from a “hold” rating to a “strong-buy” rating in a research report on Monday, June 29th. Needham & Company LLC upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $165.00 price objective for the company in a research report on Wednesday, May 27th. Finally, Weiss Ratings raised ICU Medical from a “sell (d)” rating to a “sell (d+)” rating in a research note on Monday, May 11th. Three research analysts have rated the stock with a Strong Buy rating, four have given a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $168.40.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.